Asked by: John Hayes (Conservative - South Holland and The Deepings)
Question to the Department for Environment, Food and Rural Affairs:
To ask the Secretary of State for Environment, Food and Rural Affairs, what steps his Department is taking to help reverse biodiversity loss in Lincolnshire.
Answered by Rebecca Pow - Parliamentary Under-Secretary (Department for Environment, Food and Rural Affairs)
In England we have set four legally binding targets for biodiversity: to halt the decline in species abundance by 2030; then to reverse declines by 2042; to reduce the risk of species extinction by 2042; and restore or create more than 500,000 hectares of wildlife-rich habitat, also by 2042. These targets will drive actions to support biodiversity in Lincolnshire and every other area across England.
We have set out our plan to deliver on these ambitious targets, along with our other environmental targets, in the Environmental Improvement Plan (EIP23) published 31 January 2023. Here we link the different objectives, plans and mechanisms for recovering nature.
Local Nature Recovery Strategies (LNRS) are being prepared across the whole of England to support the delivery of these targets. The 48 strategies are bringing together local partners to agree priorities and propose practical actions in areas where they would have the most benefit for nature recovery and the wider environment. Preparation of the Greater Lincolnshire LNRS is being led by Lincolnshire County Council, with support from local planning authorities in the area and Natural England.
The Lincolnshire Coronation Coast National Nature Reserve (NNR) was declared in September 2023. The newly expanded NNR will enhance the nature and biodiversity of the Greater Lincolnshire coast making it a bigger, better and more joined up area for wildlife, through bringing together the Donna Nook and Saltfleetby-Theddlethorpe Dunes Nature Reserves and adding a further 2350 hectares of land managed for nature conservation. The reserve supports many breeding and over-wintering birds, natterjack toads, special plants and insects.
Additionally, the Environment Agency is working with partners to deliver the Upper Witham River and floodplain restoration projects (currently shortlisted for the River Restoration Centre award). Over the last 10 years, habitat along 19.4 km of river has been enhanced with 19 projects: from urban habitat improvement in Grantham, to large scale river and wetland restoration in rural areas.
Asked by: Tanmanjeet Singh Dhesi (Labour - Slough)
Question to the Department for Environment, Food and Rural Affairs:
To ask the Secretary of State for Environment, Food and Rural Affairs, what recent discussions he has had with relevant stakeholders on the potential ban on importing dogs and cats under the age of six months; and what assessment he has made of the potential impact of that ban on levels of illegal pet trade.
Answered by Mark Spencer - Minister of State (Department for Environment, Food and Rural Affairs)
Defra regularly engages with relevant stakeholders, on tackling the illegal pet trade, including prohibiting the import of puppies and kittens under the age of six months.
The Government supports the Private Members’ Bill, Animal Welfare (Import of Dogs, Cats and Ferrets) Bill, introduced by Selaine Saxby MP on restricting the importation and non-commercial movement of pets. The Bill will contain powers that will enable future regulations for commercial and non-commercial movements of pets into the United Kingdom including prohibiting the import of puppies under six months old. By its very nature, it is difficult to assess the full extent of the illegal pet trade. The measures in the Bill will close loopholes exploited by unscrupulous traders, help reduce the low welfare movement of pets into Great Britain and crack down on the illegal smuggling of dogs and puppies.
Asked by: Toby Perkins (Labour - Chesterfield)
Question to the Foreign, Commonwealth & Development Office:
To ask the Deputy Foreign Secretary, whether the Government will ensure that at least 30% of the future International Climate Finance commitment will be allocated to supporting nature’s recovery.
Answered by Andrew Mitchell - Minister of State (Foreign, Commonwealth and Development Office) (Minister for Development)
We are delivering on our current International Climate Finance commitment of £11.6 billion over five years from 2021/22 to 2025/26, including at least £3 billion to be spent on development solutions that protect and restore nature. The recently published Development White Paper includes a commitment to work globally to improve the quantity, quality and accessibility of climate and nature finance. Our own future funding commitments beyond 2025/26 will be agreed through the spending review process.
Asked by: Martyn Day (Scottish National Party - Linlithgow and East Falkirk)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, with reference to the Answer of 14 March 2022 to Question 133232 on Antibiotics: Drug Resistance and to the policy paper entitled UK five-year action plan for antimicrobial resistance: 2019 to 2024, published on 24 January 2019, what recent progress her Department has made on halving healthcare-associated Gram-negative blood stream infections.
Answered by Maria Caulfield - Parliamentary Under Secretary of State (Department for Business and Trade) (Minister for Women)
As described in the answer of 14 March 2022 to Question 133232, progress towards the target of halving healthcare-associated Gram-negative bloodstream infections (GNBSI) has proved very challenging, in part due to the diverse nature of the underlying causes of these infections. Data on the incidence of these infections in England is published quarterly by the UK Health Security Agency, and is available at the following link:
Incidence of the three main healthcare-associated GNBSI organisms, E. coli, klebsiella pneumoniae, and pseudomonas aeruginosa, has fluctuated between 2019 and 2024, including a sharp decline in the incidence of E. coli seen during the COVID-19 pandemic. However, overall, the total incidence of healthcare associated GNBSI remains significantly above the target.
We are currently developing the 2024 to 2029 antimicrobial resistance national action plan. We anticipate that in the delivery of this plan, we will continue to focus on GNBSI, building on lessons learnt over the past five years.
Asked by: Lisa Nandy (Labour - Wigan)
Question to the Foreign, Commonwealth & Development Office:
To ask the Deputy Foreign Secretary, what recent discussions has he had with partners in West Africa on partnerships relating to climate mitigation.
Answered by Andrew Mitchell - Minister of State (Foreign, Commonwealth and Development Office) (Minister for Development)
The UK is a strong supporter of climate action in West Africa, helping countries transition to a low carbon economy and adapt to the impacts of climate change. The Africa Regional Climate and Nature Programme (ARCAN) is a regional programme of up to £250 million over 6 years which aims to build resilience to climate change, tackle nature and biodiversity loss and catalyse energy transition in Sub-Saharan Africa. I [Minister Mitchell] have engaged with a range of West African partners and led the UK delegation at the African Climate Summit in Nairobi in September 2023, and COP28 in Dubai in December 2023. During a visit to Accra in January 2024 I met Secretary General of the Climate Vulnerable Forum (CVF), President Nasheed, and discussed priorities for the CVF and its Vulnerable Twenty (V20) Group.
Asked by: Gregory Campbell (Democratic Unionist Party - East Londonderry)
Question to the Department for Education:
To ask the Secretary of State for Education, if she will make an assessment of the lessons learned for her Department of the implementation of the skills electrification project element of the emerging skills projects.
Answered by Luke Hall - Minister of State (Education)
The Skills Electrification Project was part of the Emerging Skills Projects, which were pilot projects funded by the department to identify future skills needs and develop high-quality modular courses to help address future skills gaps in key sectors. The Skills Electrification Project, as well as the other emerging skills projects, were developed and run by the Advanced Manufacturing Catapult and completed in March 2022.
The department recognises the changing nature of skills needs, the importance of emerging skills such as electrification and assesses skills needs for such sectors. For example, the National Grid estimates the electricity network workforce will grow by 400,000 roles by 2050. This includes 260,000 brand new roles, and 140,000 to replace natural attrition such as retirement. This is on top of the existing shortage of crucial workers in the sector.
To help meet those needs there are three apprenticeship standards that directly serve the electricity networks sector: community energy specialist (Level 4), building energy management systems (Level 4) and power networks craftsperson (Level 3).
Free Courses for Jobs also offers a range of qualifications in electrical disciplines, as well as digital engineering and electrotechnical installation.
T Levels in engineering and construction teach young people some of the skills that are crucial to the growth of the UK’s energy networks. Relevant T Levels in engineering, manufacturing, and construction can lead to crucial occupations such as civil engineering technician, electrical engineering technician and technical surveyor.
Asked by: Chi Onwurah (Labour - Newcastle upon Tyne Central)
Question to the Department for Science, Innovation & Technology:
To ask the Secretary of State for Science, Innovation and Technology, whether her Department has taken steps to align the activities of UK Research and Innovation and the UK Health Security Agency.
Answered by Andrew Griffith - Minister of State (Department for Science, Innovation and Technology)
UK Research and Innovation (UKRI) and UK Health Security Agency (UKHSA) have complementary roles in preparing for and responding to infectious diseases threats, working in partnership with Department of Health and Social Care/National Institute Health and Care Research and Department of Environment, Food and Rural Affairs taking a ‘One Health’ approach. To enhance UK preparedness and resilience, UKRI works closely with UKHSA and government departments to ensure the UK has appropriate infrastructure and capabilities to prevent, detect and respond to future threats. In responding to disease outbreaks, UKRI works with UKHSA and devolved administrations, who provide vital leadership on the nature of the threats and the research questions to be addressed.
Asked by: Ashley Dalton (Labour - West Lancashire)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what assessment she has made of the potential impact of the guidance submitted to medical professions on the prescription of semaglutide on the availability of that drug for people suffering from type 2 diabetes.
Answered by Andrew Stephenson - Minister of State (Department of Health and Social Care)
The Department has worked intensively with industry to seek commitments from them to address issues with the supply of glucagon-like peptide-1 receptor agonists (GLP-1 RAs), including semaglutide, to expedite deliveries and boost supplies. As a result, the overall supply position in the United Kingdom has improved. Guidance for healthcare professionals now allows for the initiation of new patients on Rybelsus tablets, an oral semaglutide, and provides advice on what to prescribe patients who are unable to obtain their existing GLP-1 RA treatment whilst there continue to be disruptions to the supply of some products, including semaglutide. These disruptions are affecting many countries around the world, and aren’t specific to the UK.
We continue to work with international partners, given the global nature of medical supply chains, collaborating to share best practice and manage and respond to common threats to supply, including on semaglutide and other GLP-1 RAs licensed for treating patients with type 2 diabetes.
Asked by: Ashley Dalton (Labour - West Lancashire)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, whether she is working with her international counterparts to tackle supply issues relating to (a) semaglutide and (b) other glucagon-like peptide-1 receptor agonists licensed for treating patients with type 2 diabetes.
Answered by Andrew Stephenson - Minister of State (Department of Health and Social Care)
The Department has worked intensively with industry to seek commitments from them to address issues with the supply of glucagon-like peptide-1 receptor agonists (GLP-1 RAs), including semaglutide, to expedite deliveries and boost supplies. As a result, the overall supply position in the United Kingdom has improved. Guidance for healthcare professionals now allows for the initiation of new patients on Rybelsus tablets, an oral semaglutide, and provides advice on what to prescribe patients who are unable to obtain their existing GLP-1 RA treatment whilst there continue to be disruptions to the supply of some products, including semaglutide. These disruptions are affecting many countries around the world, and aren’t specific to the UK.
We continue to work with international partners, given the global nature of medical supply chains, collaborating to share best practice and manage and respond to common threats to supply, including on semaglutide and other GLP-1 RAs licensed for treating patients with type 2 diabetes.
Asked by: Ashley Dalton (Labour - West Lancashire)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps she is taking with pharmaceutical companies to increase the supply of semaglutide.
Answered by Andrew Stephenson - Minister of State (Department of Health and Social Care)
The Department has worked intensively with industry to seek commitments from them to address issues with the supply of glucagon-like peptide-1 receptor agonists (GLP-1 RAs), including semaglutide, to expedite deliveries and boost supplies. As a result, the overall supply position in the United Kingdom has improved. Guidance for healthcare professionals now allows for the initiation of new patients on Rybelsus tablets, an oral semaglutide, and provides advice on what to prescribe patients who are unable to obtain their existing GLP-1 RA treatment whilst there continue to be disruptions to the supply of some products, including semaglutide. These disruptions are affecting many countries around the world, and aren’t specific to the UK.
We continue to work with international partners, given the global nature of medical supply chains, collaborating to share best practice and manage and respond to common threats to supply, including on semaglutide and other GLP-1 RAs licensed for treating patients with type 2 diabetes.